RAF709
CAS: 1628838-42-5
Ref. 3D-DQC83842
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Product Information
RAF709 is a small molecule that is effective against cancer cells in vitro and in vivo. It activates the extracellular signal-regulated kinase (ERK) pathway by binding to Raf, which leads to autophagy and cell death. RAF709 has been shown to be effective against cancers of the breast, ovary, colon, lung, prostate, bladder, kidney, thyroid gland and skin. The effective dose is dependent on the cancer type: for example, RAF709 inhibits cancer growth in murine xenografts at doses as low as 1 mg/kg body weight when administered orally or intraperitoneally. This drug also has an amide group that confers selectivity for Raf over other protein kinases and may have additional biological activity beyond its effects on ERK signaling.
Chemical properties
Technical inquiry about: 3D-DQC83842 RAF709
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
